Related Experiment Video
Updated: Feb 27, 2026

Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System
Published on: October 22, 2020
Early Postnatal Secondhand Smoke Exposure Disrupts Bacterial Clearance and Abolishes Immune Responses in
Brandon W Lewis1, Razia Sultana1, Rahul Sharma2
1Department of Comparative Biomedical Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge, LA 70803.
Insights
Early secondhand smoke (SHS) exposure in mice impairs lung antibacterial defenses and immune responses, increasing susceptibility to infections. These effects are reversible but can lead to long-term lung damage.
Area of Science:
- Pulmonary Medicine
- Immunology
- Environmental Health
Background:
- Secondhand smoke (SHS) exposure is linked to worsening lung diseases.
- Its impact on pediatric muco-obstructive airway diseases like cystic fibrosis is unclear.
Purpose of the Study:
- To investigate the effects of early postnatal SHS exposure on lung development and immune function in a mouse model of muco-obstructive lung disease.
Main Methods:
- Exposed Scnn1b transgenic mice to SHS from postnatal day 3-21.
- Assessed lung phenotypes, bacterial infection clearance, immune cell recruitment, and gene expression at postnatal day 22.
- Evaluated reversibility of effects after SHS cessation.
Main Results:
- SHS-exposed mice failed to clear bacterial infections, showing suppressed phagocyte recruitment, IgA secretion, and Muc5b expression.
- SHS exposure downregulated IL-33, leading to reduced neutrophil recruitment and Th2 responses.
- While some immune responses recovered after SHS cessation, mice showed persistent lung damage like epithelial necrosis and alveolar consolidation.
Conclusions:
- Early postnatal SHS exposure reversibly suppresses IL-33, impairing antibacterial defenses and Th2 responses.
- Household smoking may predispose neonates with muco-obstructive lung disease to bacterial exacerbations and long-term lung injury.
Abstract:
Secondhand smoke (SHS) exposure has been linked to the worsening of ongoing lung diseases. However, whether SHS exposure affects the manifestation and natural history of imminent pediatric muco-obstructive airway diseases such as cystic fibrosis remains unclear. To address these questions, we exposed Scnn1b transgenic (Scnn1b-Tg+) mice to SHS from postnatal day (PND) 3-21 and lung phenotypes were examined at PND22. Although a majority of filtered air (FA)-exposed Scnn1b-Tg+ (FA-Tg+) mice successfully cleared spontaneous bacterial infections by PND22, the SHS-exposed Scnn1b-Tg+ (SHS-Tg+) mice failed to resolve these infections. This defect was associated with suppressed antibacterial defenses, i.e., phagocyte recruitment, IgA secretion, and Muc5b expression. Whereas the FA-Tg+ mice exhibited marked mucus obstruction and Th2 responses, SHS-Tg+ mice displayed a dramatic suppression of these responses. Mechanistically, downregulated expression of IL-33, a stimulator of type II innate lymphoid cells, in lung epithelial cells was associated with suppression of neutrophil recruitment, IgA secretions, Th2 responses, and delayed bacterial clearance in SHS-Tg+ mice. Cessation of SHS exposure for 21 d restored previously suppressed responses, including phagocyte recruitment, IgA secretion, and mucous cell metaplasia. However, in contrast with FA-Tg+ mice, the SHS-Tg+ mice had pronounced epithelial necrosis, alveolar space consolidation, and lymphoid hyperplasia; indicating lagged unfavorable effects of early postnatal SHS exposure in later life. Collectively, our data show that early postnatal SHS exposure reversibly suppresses IL-33 levels in airspaces which, in turn, results in reduced neutrophil recruitment and diminished Th2 response. Our data indicate that household smoking may predispose neonates with muco-obstructive lung disease to bacterial exacerbations.
Related Concept Videos
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Pulmonary Cycle: Exhalation
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-I: Introduction
Breathing

